Investors

Where Innovation Meets Impact.

AI-Powered Platforms Transforming Digital Health and Driving Shareholder Value

Why Invest in AIML?

We are pioneering the future of health intelligence by developing and commercializing advanced AI-driven technologies that unlock powerful biometric insights

Backed by a growing portfolio of proprietary technologies and a world-class leadership team, AIML is committed to delivering long-term value to shareholders while improving health outcomes across global markets.

April 22, 2025

AIML Innovations Appoints Jared Adelstein to Board of Directors

Press Releases
April 22, 2025
AIML Innovations Appoints Jared Adelstein to Board of Directors
Read More
April 15, 2025
AIML Announces Closing of Oversubscribed Private Placement
Read More
April 7, 2025
AIML Updates Terms of Proposed Private Placement Announced
Read More
April 4, 2025
AIML Announces Proposed Private Placement
Read More
March 21, 2025
AIML Continues to Streamline for the Future and Moves Beyond Tech2Heal
Read More
March 14, 2025
AIML Aligns Leadership for Growth and Shareholder Value Creation
Read More
Press Releases Archive
Read more
Corporate Governance
Board of Directors

Paul Duffy

Executive Chairman

Dr. Drew Dundas

Independent

Tim Daniels

Director

Peter Kendall

Director
Financials

Read more on CSE

AGM Materials
Information Circular
Notice and Access
Form of Proxy
Financial Request Form
Information Circular
Notice and Access
Form of Proxy & Return Card
Notice of Meeting and Information Circular
Form of Proxy and Return Card

Historic AGM materials can be found under the company’s profile on SEDAR+

Charters & Policies
Corporate Disclosure and Insider Trading Policy
Code of Business Conduct and Ethics
Audit Committee Charter
Whistleblower Policy
Company Structure
173.3
Million
Shares Outstanding
9.1
Million
Options
109.4
Million
Warrants Outstanding
291.8
Million
Fully Diluted